Skip to main content
Clinical Trials/CTRI/2021/02/031318
CTRI/2021/02/031318Not yet recruitingNot Applicable

AN OPEN LABEL SINGLE ARM CLINICAL STUDY ON COMBINED THE COMBINED EFFECTIVENESS OF PANCHANIMBAKAMCHURNA VATI AND PATHYADI LEPA IN KITIBA KUSHTA(PSORIASIS)

SDM College of Ayurveda Hassan1 site in 1 country30 target enrollmentStarted: February 22, 2021Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Improvement in the PASI scale and symptoms of Kitibha Kushta

Study Overview

Brief Summary

This study is an open label single arm prospective clinical study to assess the effectiveness of panchanimbakam churna vati and pathyadi lepa in management of kitibha kushta within age group of 18 to 60 for 30 days in 30 patients. The study will be conducted in  one center in India. Secondary outcomes will be assessed by Pasi scale after 30 days

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients suffering with Kitibha Kushta <5years of chronicity.
  • Patients of either gender, aged between 18-60 years.
  • Patient willing to participate in the study and ready to sign informed consent form.

Exclusion Criteria

  • Patients with systemic illness such as impaired cardiac, renal and hepatic functions.
  • Metabolic disorders namely diabetes mellitus type 2 and essential hypertension.
  • Pregnant women and lactating women.

Outcomes

Primary Outcomes

Improvement in the PASI scale and symptoms of Kitibha Kushta

Time Frame: outcomes will be assessed at baseline, 15 days and 30 days

Secondary Outcomes

  • PASI scale(15 days and 30 days)

Investigators

Sponsor
SDM College of Ayurveda Hassan
Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials